Soliqua® (insulin glargine and lixisenatide)
for Diabetes Type 2

Soliqua (insulin glargine/lixisenatide) is a combination medication used to lower blood sugar levels in people with type 2 diabetes. It contains insulin glargine, which helps regulate sugar metabolism by moving sugar into cells and reducing liver sugar production, and lixisenatide, a GLP-1 receptor agonist that increases insulin release after meals, prevents sugar release from the liver, and slows food movement through the digestive system.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Diabetes Type 2